Form 8-K - Current report:
SEC Accession No. 0001079973-24-001121
Filing Date
2024-07-30
Accepted
2024-07-30 08:05:08
Documents
15
Period of Report
2024-07-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 32400
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 5178
  Complete submission text file 0001079973-24-001121.txt   257117

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE scpx-20240729.xsd EX-101.SCH 3549
4 XBRL DEFINITION FILE scpx-20240729_def.xml EX-101.DEF 26579
5 XBRL LABEL FILE scpx-20240729_lab.xml EX-101.LAB 36527
6 XBRL PRESENTATION FILE scpx-20240729_pre.xml EX-101.PRE 25203
17 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5512
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 241154452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)